Search
Browse Categories

Bladder Human Tissue Microarray, 63 Cases and 63 Cores


Price: $270.00
Item Number: UBD632
Arrayit Bladder Human Tissue Microarray, 63 Cases and 63 Cores is a bladder cancer array with bladder tissue, including TNM and clinical stage, 63 cases/63 cores. Arrayit offers an extensive line of more than 1,000 high quality tissue microarrays for basic and cancer research, life sciences, clinical and histological applications. Tissue microarrays (TMAs) are glass slides (1 x 25 x 76 mm) containing thin section miniaturized arrays of paraffin-embedded cylindrical tissue cores. Arrayit tissue microarrays are manufactured using more than 50 different human tissues obtained from surgical pathology, autopsy and other sources, embedded in paraffin to create donors blocks. A tissue microarrayer punches miniature cylindrical tissue cores from the donor blocks and prints them in a defined pattern at high density into recipient blocks such that dozens or hundreds of tissue cores can be printed into the recipient blocks. A microtome is used to cut thin sections from the recipient blocks and the tissue sections are transferred onto glass slides to complete the tissue microarray manufacturing process. TMA slides are analyzed using powerful techniques including histochemical staining, immunohistochemical staining, immunofluorescent staining and in situ hybridization with DNA or mRNA probes. Because multiple patient samples are analyzed in a massively parallel format, TMAs greatly reduce experimental variability and technical artifacts compared to traditional techniques. Clinical cancer patient cohorts and corresponding tissue microarray sets have been used to study diagnostic, prognostic and treatment predictive cancer biomarkers in most forms of cancer including lung, breast, colorectal and renal cell cancer. Tissue microarrays and immunohistochemistry have been combined in large scale efforts to create a protein expression map on a proteomic scale. Arrayit Bladder Human Tissue Microarray, 63 Cases and 63 Cores ships as 1 tissue microarray slide per order.

 

:tissue-microarray.jpg

Arrayit offers more than 1,000 high quality tissue microarrays for basic and cancer research, life sciences, clinical and histological applications. Tissue microarrays (TMAs) are glass slides (1 x 25 x 76 mm) containing thin section miniaturized arrays of paraffin-embedded cylindrical tissue cores. TMA slides are analyzed using powerful techniques including histochemical staining, immunohistochemical staining, immunofluorescent staining and in situ hybridization with DNA or mRNA probes. Because multiple patient tissue samples are analyzed in a miniaturized and massively parallel format, TMAs greatly reduce experimental variability and technical artifacts and speed histological analysis compared to traditional techniques.

 

Technical Support

Please contact us by email arrayit@arrayit.com for worldwide technical support.

 

Scientific Publications

Click here and here for Arrayit tissue microarray scientific publications.

 

Ordering Information

No.

Catalog ID

Rows

Columns

Cases

Cores

Category

Description

1

DAG241

3

8

6

24

Adrenal Gland

Adrenal gland tumor with adrenal gland tissue test array, 6 cases/24 cores

2

EAG1601

10

16

80

160

Adrenal Gland

Adrenal gland tumor tissue array, including pathology grade, TNM and clinical stage, 80 cases/160 cores

3

EAG-2081a

12

16

96

192

Adrenal Gland

Adrenal gland disease spectrum (adrenal gland cancer progression) tissue array (2017 WHO classification), including TNM and clinical stage (AJCC 7th edition), 96 cases/192 cores, replacing AD2081

4

EAG481

6

8

24

48

Adrenal Gland

Adrenal gland tumor tissue array with normal tissue, including pathology grade, TNM and clinical stage, 24 cases/48 cores

5

EAG721

8

9

72

72

Adrenal Gland

Adrenal gland tumor tissue array, including pathology grade, TNM and clinical stage, 72 cases/72 cores

6

DAP1001

10

10

50

100

Appendix

Vermiform appendix disease spectrum (vermiform appendix cancer progression) tissue array, including pathology grade, 50 cases/100 cores

7

DAP241

3

8

6

24

Appendix

Appendix cancer with appendix tissue test array, including pathology grade, TNM and clinical stage, 6 cases/24 cores

8

BL2081c

12

16

191

192

Bladder

Bladder cancer with bladder tissue array, including pathology grade, TNM and clinical stage, 191 cases/192 cores, replacing BL2081b

9

BL241a

4

6

10

24

Bladder

Bladder cancer tissue array with matched cancer adjacent tissue, including pathology grade, TNM and clinical stage, 10 cases/24 cores, replacing BL241

10

BL482

6

8

48

48

Bladder

Bladder cancer tissue array, including pathology grade, TNM and clinical stage, 48 cases/48 cores

11

BL601c

6

10

60

60

Bladder

Bladder cancer (stage III-IV) tissue array, including TNM and clinical stage, 60 cases/60 cores, replacing BL601b

12

BL805a

8

10

80

80

Bladder

Mid-advanced stage bladder cancer tissue array, with metastasis tissue, including TNM and pathology grade, 80 cases/80 cores, replacing BL805

13

BLA501

6

9

50

50

Bladder

Bladder cancer with bladder tissue array (2016 WHO classification), including pathology grade, TNM and clinical stage (AJCC 7th edition), 50 cases/50 cores

14

UBD1001

10

10

25

100

Bladder

Bladder tumor tissue array, including TNM and clinical stage, 25 cases/100 cores

15

UBD1002a

10

10

50

100

Bladder

Bladder cancer array with cancer adjacent tissue, including TNM and pathology grade, 50 cases/100 cores

16

UBD1003

10

10

50

100

Bladder

Bladder cancer tissue array with bladder tissue, including TNM and clinical stage, 50 cases/100 cores

17

UBD1501

10

15

75

150

Bladder

Bladder cancer tissue array, including pathology grade, TNM and clinical stage, 75 cases/150 cores

18

UBD1921

12

16

96

192

Bladder

Middle-advanced stage bladder cancer tissue array, including pathology grade, TNM and clinical stage, 96 cases/192 cores

19

UBD241

3

8

6

24

Bladder

Bladder cancer with bladder tissue test array, including pathology grade, TNM and clinical stage, 6 cases/24 cores, replacing T121

20

UBD242

3

8

6

24

Bladder

Bladder cancer with bladder tissue test array, including pathology grade, TNM and clinical stage, 2 serial sections, 6 cases/24 cores

21

UBD243

3

8

12

24

Bladder

Bladder cancer tissue array with normal bladder tissue, including pathology grade, TNM and clinical stage, 12 cases/24 cores, replacing T124a

22

UBD243a

4

6

12

24

Bladder

Bladder cancer tissue array with cancer adjacent tissue, including TNM and clinical stage, 12 cases/24 cores, replacing BL243

23

UBD244

4

6

6

24

Bladder

Bladder cancer tissue array, including pathology grade, TNM and clinical stage, 6 cases/24 cores

24

UBD541

7

8

27

54

Bladder

Different stages bladder cancer tissue array with matched adjacent normal or cancer adjacent tissue, including pathology grade, TNM and clinical stage, 27 cases/54 cores

25

UBD601b

6

10

60

60

Bladder

Bladder cancer (stage III-IV) tissue array, including TNM and clinical stage, 60 cases/60 cores, replacing BL601a

26

UBD632

7

9

63

63

Bladder

Bladder cancer array with bladder tissue, including TNM and clinical stage, 63 cases/63 cores

27

UBD641

8

8

64

64

Bladder

Urothelial carcinoma tissue array, including pathology grade, TNM and clinical stage, 64 cases/64 cores

28

UBD721

8

9

24

72

Bladder

Bladder cancer tissue array with adjacent normal tissue, including TNM and clinical stage, 24 cases/72 cores

29

UBD802

8

10

78

80

Bladder

Bladder cancer tissue array with bladder tissue, including TNM and clinical stage, 78 cases/80 cores

30

UBD803

8

10

40

80

Bladder

Bladder cancer tissue array with normal tissue, including TNM and clinical stage, 40 cases/80 cores

31

UBD811

9

9

81

81

Bladder

Bladder cancer tissue array with bladder tissue, including TNM and pathology grade, 81 cases/81 cores

32

UBD812

9

9

27

81

Bladder

Bladder cancer tissue array with bladder tissue, including pathology grade, TNM and clinical stage, 27 cases/81 cores

33

UBD901

9

10

90

90

Bladder

Different stage of bladder cancer tissue array, including TNM and clinical stage, 90 cases/90 cores

34

UBD902

9

10

90

90

Bladder

Multiple of bladder cancer tissue array with bladder tissue, including pathology grade, TNM and clinical stage, 90 cases/90 cores

35

DPA2081d

12

16

96

192

Bladder 

Pancreas disease spectrum (pancreatic cancer progression) with pancreas tissue array, including pathology grade, TNM and clinical stage, 96 cases/192 cores, replacing PA2081c

36

UBD2082b

13

16

208

208

Bladder 

Bladder cancer tissue array, including TNM and clinical stage, 208 cases/208 cores, replacing BL2082a

37

UBD208a

12

16

64

192

Bladder 

Multiple bladder cancer with bladder tissue array, with metastatic carcinoma, including pathology grade, TNM and clinical stage, 64 cases/192 cores, replacing BL208

38

UBD601

6

10

60

60

Bladder 

Bladder cancer (stage III-IV) tissue array, including pathology grade, TNM and clinical stage, 60 cases/60 cores

39

UBD806c

8

10

66

80

Bladder 

Bladder cancer and bladder tissue array, including pathology grade, TNM and clinical stage, 66 cases/80 cores, replacing BL806b

40

S-OSCS1602M

8

10

80

80

Bone

Combined microarray for osteosarcoma and chondrosarcoma with survival data, including TNM, survival status and clinical stage, 80 cases/80 cores

41

BON501

6

9

50

50

Bone Cartilage

Osteosarcoma tissue with normal tissue array, including TNM and clinical stage, 50 cases/50 cores

42

LBN241

3

8

6

24

Bone Cartilage

Bone and cartilage tumor with normal tissue array, including TNM and clinical stage, 6 cases/24 cores

43

LBN244f

3

8

12

24

Bone Cartilage

Normal bone tissue array with osteosarcoma tissue, including TNM and clinical stage, 12 cases/24 cores

44

LBN246

4

6

12

24

Bone Cartilage

Bone, cartilage tumor with adjacent normal tissue array, including TNM and clinical stage, 12 cases/24 cores

45

LBN247

3

8

6

24

Bone Cartilage

Bone tumor and cartilage tumor tissue array, with bone tissue, including TNM and clinical stage, 6 cases/24 cores

46

LBN262a

3

8

12

24

Bone Cartilage

Bone tumor test tissue array with normal tissue as control, including TNM, clinical stage, 12 cases/24 cores, replacing T262

47

LBN481

6

8

48

48

Bone Cartilage

Bone and cartilage tumor tissue array with adjacent normal bone tissue, including TNM and clinical stage, 48 cores/48 cases

48

LBN802

8

10

80

80

Bone Cartilage

Osteosarcoma and chondrosarcoma tissue array, including TNM and clinical stage, 80 cases/80 cores

49

LBN805

8

10

80

80

Bone Cartilage

Chondrosarcoma tissue array, 80 cases/80 cores

50

LBN811

9

9

27

81

Bone Cartilage

Chondrosarcoma tissue array, 27 cases/81 cores

51

LBO804e

8

10

40

80

Bone Cartilage

Osteosarcoma tissue array, including TNM and clinical stage, 40 cases/80 cores

52

OS802e

8

10

80

80

Bone Cartilage

Osteosarcoma and chondrosarcoma tissue array, including TNM and clinical stage, 80 cases/80 cores, replacing OS802c

53

BO481b

6

8

48

48

Bone Cartilage

Bone and cartilage tumor with bone tissue array, including TNM and clinical stage, 48 cores/48 cases, replacing BO481a

54

BCC26012

4

6

24

24

Bone Marrow

Osteochondroma with adjacent normal tissue array, 24 cases/24 cores

55

BM241a

4

6

12

24

Bone Marrow

Bone marrow tissue array, 12 cases/24 cores, replacing BM241

56

BN29011b

6

10

33

60

Bone Marrow

Bone marrow, spleen and lymph node tissue array, 33 cases/60 cores, replacing BN29011a

57

BOM501

6

9

50

50

Bone Marrow

Normal bone marrow tissue array, 50 cases/50 cores

58

IBM241

3

8

6

24

Bone Marrow

Bone marrow tumor and normal tissue array, including TNM and pathology grade, 6 cases/24 cores, replacing T293

59

IBM291c

3

8

6

24

Bone Marrow

Myeloma tissue array with normal bone marrow tissue, 6 cases/24 cores, replacing T291b

60

IBM291d

3

8

6

24

Bone Marrow

Myeloma tissue array with bone marrow tissue, 6 cases/24 cores

61

IBM481

7

8

24

48

Bone Marrow

Normal bone marrow tissue array, 24 cases/48 cores

62

LBM481a

7

8

24

48

Bone Marrow

Normal bone marrow tissue array, 24 cases/48 cores

63

LBN245

4

6

12

24

Bone Marrow

Bone marrow tissue array, 12 cases/24 cores

64

LBN483c

6

8

24

48

Bone Marrow

Bone tumor and adjacent normal tissue array, including TNM and clinical stage, 24 cases/48 cores, replacing BM483b

65

LBN483d

6

8

24

48

Bone Marrow

Bone tumor and adjacent normal tissue array, including TNM and clinical stage, 24 cases/48 cores

66

LBN601

6

10

30

60

Bone Marrow

Bone marrow, spleen and lymph node tissue array, 30 cases/60 cores

67

GL1001b

10

10

100

100

Brain

Brain cancer and brain tissue array as control, including pathology grade, 100 cases/100 cores, replacing GL1001a

68

GL151a

3

5

15

15

Brain

Ependymoma tissue array, including pathology grade, 15 cases/15 cores, replacing GL151

69

GL241d

4

6

12

24

Brain

Brain tumor with brain tissue array, including pathology grade, 12 cases/24 cores, replacing GL241c

70

GL722a

8

9

24

72

Brain

Brain glioma and normal tissue array, including pathology grade, 24 cases/72 cores, replacing GL722

71

GL804a

8

10

40

80

Brain

Brain tumor and brain tissue array, including pathology grade, 40 cases/80 cores

72

MG801a

8

10

80

80

Brain

Meningioma of central nerve tissue array, 80 cases/80 cores, replacing MG801

73

NCT1002

10

10

50

100

Brain

Brain tumor and normal tissue array, 50 cases/100 cores

74

NCT175b

3

8

12

24

Brain

Brain tumor tissue array with brain tissue, including pathology grade, 12 cases/24 cores, replacing T175a

75

NCT1921

12

16

96

192

Brain

Brain tumor tissue array, including pathology grade, 96 cases/192 cores

76

NCT1921a

12

16

96

192

Brain

Brain tumor tissue microarray, containing 96 cases of tumor (47 astrocytoma, 41 glioblastoma, 3 ependymoma, 2 each of ganglion glioma and gliosarcoma, 1 medulloblastoma), duplicate cores per case, divided into two identical 96 core arrays, suitable for therapeutic antibody screening

77

NCT2083b

13

16

208

208

Brain

Brain tumor tissue array, including pathology grade, 208 cases/208 cores, replacing GL2083a

78

NCT241c

4

6

12

24

Brain

Brain tumor with brain tissue array, including pathology grade, 12 cases/24 cores, replacing GL241b

79

NCT242

4

12

24

48

Brain

Brain tumor tissue array with normal tissue, including pathology grade, 2 serial sections, 24 cases/48 cores

80

NCT243

4

6

6

24

Brain

Brain tumor tissue array, including pathology grade, 6 cases/24 cores

81

NCT481

6

8

48

48

Brain

Brain tumor tissue array, including pathology grade, 48 cases/48 cores

82

NCT482

6

8

48

48

Brain

Brain tumor tissue array with normal tissue, including pathology grade, 48 cases/48 cores

83

NCT631

7

9

63

63

Brain

Brain tumor tissue array, including pathology grade, 63 cases/63 cores

84

NCT632

7

9

63

63

Brain

Brain tumor with cancer adjacent brain tissue array, including pathology grade, 63 cases/63 cores

85

NCT721

8

9

24

72

Brain

Brain tumor with brain tissue array, including pathology grade, 24 cases/72 cores

86

NCT722b

8

9

24

72

Brain

Brain glioma with normal tissue array, including pathology grade, 24 cases/72 cores

87

NCT741

8

10

26

74

Brain

Normal brain tissue array, 26 cases/74 cores

88

NCT801

8

10

79

80

Brain

Brain disease spectrum (brain cancer progression) tissue array, including pathology grade, TNM and clinical stage, 79 cases/80 cores

89

NCT802

8

10

40

80

Brain

Brain tumor tissue array, 40 cases/80 cores

90

NCT805

8

10

40

80

Brain

Brain glioblastoma tissue array with normal tissue, including pathology grade, 40 cases/80 cores

91

NCT808

8

10

35

80

Brain

Brain tumor tissue array with matched cancer adjacent or adjacent normal tissue, including pathology grade, 35 cases/80 cores

92

NCT811

8

10

27

81

Brain

Brain tumor and normal tissue array, including pathology grade, 27 cases/81 cores

93

NCT861

9

10

43

86

Brain

Brain metastatic carcinoma tissue array, including pathology grade, 43 cases/86 cores

94

NCT961

8

12

96

96

Brain

Multiple types brain tumor tissue array, including pathology grade, 96 cases/96 cores

95

NGL-241b

4

6

24

24

Brain

Normal cerebrum tissue array, 24 cases/24 cores, replacing GLN241

96

RAT301

5

6

30

30

Brain

Rat brain tissue array, 30 cases/30 cores

97

RAT301a

5

6

30

30

Brain

Rat brain tissue array, 30 cases/30 cores, replacing RAT301

98

SSO808

6

10

30

60

Brain

Schwannoma (neurilemmoma or neurinoma) of central nerve tissue array, 30 cases/60 cores

99

YNB642b

7

10

32

64

Brain

Neuroblastoma and peripheral nerve tissue array, including TNM and INSS stage, 32 cases/64 cores, replacing NB642a

100

YNB642c

7

10

32

64

Brain

Neuroblastoma and peripheral nerve tissue array, including TNM and clinical stage, 32 cases/64 cores, replacing NB642a

101

B-Her

1

5

5

5

Breast

Breast cancer tissue array, including pathology grade, TNM, clinical stage and Her-2 marker, 5 cases/5 cores

102

BR1003c

10

11

47

101

Breast

Breast disease spectrum tissue array, including pathology grade, TNM and clinical stage, 47 cases/101 cores, replacing BR1003b

103

BR1006b

10

10

50

100

Breast

Breast cancer tissue array, including pathology grade, TNM and clinical stage, 50 cases/100 cores, replacing BR1006a

104

BR1008a

10

10

100

100

Breast

Breast cancer, lymph node metastatic carcinoma and adjacent normal tissue array, including pathology grade, TNM and clinical stage, 100 cases/100 cores, replacing BR1008

105

BR1081

11

10

54

108

Breast

Breast cancer tissue array, including pathology grade, TNM and clinical stage, 54 cases/108 cores

106

BR1201b

10

12

60

120

Breast

Breast cancer tissue array (most of triple negative), including pathology grade, TNM, clinical stage , 60 cases/120 cores, replacing BR1201a

107

BR1202b

10

12

60

120

Breast

Breast cancer tissue array (most of triple negative), including pathology grade, TNM and clinical stage, 60 cases/120 cores, replacing BR1202a

108

BR1321

12

11

120

132

Breast

Breast cancer tissue array with lymph node positive and negative, with cancer adjacent tissue, including pathology grade, TNM and clinical stage, 120 cases/ 132 cores

109

BR1504c

10

15

75

150

Breast

Breast cancer with breast tissue array, including pathology grade, TNM and clinical stage, 75 cases/150 cores, replacing BR1504b

110

BR1505f

10

15

75

150

Breast

Breast cancer tissue array, including pathology grade, TNM and clinical stage, 75 cases/150 cores, replacing BR1505e

111

BR1509a

10

15

50

150

Breast

Breast cancer tissue array (most of triple negative), including pathology grade, TNM, clinical stage, 50 cases/150 cores

112

BR1510

10

15

50

150

Breast

Breast cancer tissue array (most of Her-2 subtype), including molecular typing, pathology grade, TNM and clinical stage, 50 cases/150 cores

113

BR201

4

5

20

20

Breast

Breast disease spectrum tissue array, including pathology grade, TNM and clinical stage, 20 cases/20 cores

114

BR20824

13

16

104

208

Breast

Breast tumor tissue array (18 of 25), including pathology grade, TNM, clinical stage,104 cases/208 cores

115

BR20825

13

16

104

208

Breast

Breast tumor survey tissue array (19 of 25), including pathology grade, TNM, clinical stage, 104 cases/208 cores

116

BR20828

13

16

104

208

Breast

Breast cancer survey tissue array (22 of 25), including pathology grade, TNM and clinical stage, 104 cases/208 cores

117

BR20830

13

16

104

208

Breast

Breast tumor survey tissue array (24 of 25), including pathology grade, TNM and clinical stage, 104 cases/208 cores

118

BR20831

13

16

104

208

Breast

Breast cancer survey tissue array (25 of 25), including pathology grade, TNM and clinical stage, 104 cases/208 cores

119

BR20832

13

16

208

208

Breast

Breast tumor survey tissue array (1 of 5), with adjacent normal tissue, including pathology grade, TNM and clinical stage, 208 cases/208 cores

120

BR20833

13

16

208

208

Breast

Breast tumor survey tissue array (2 of 5), with adjacent normal tissue, including pathology grade, TNM and clinical stage, 208 cases/208 cores

121

BR20834

13

16

208

208

Breast

Breast tumor survey tissue array (3 of 5), with adjacent normal tissue, including pathology grade, TNM and clinical stage, 208 cases/208 cores

122

BR20835

13

16

208

208

Breast

Breast tumor survey tissue array (4 of 5), with adjacent normal tissue, including pathology grade, TNM and clinical stage, 208 cases/208 cores

123

BR20836

13

16

208

208

Breast

Breast cancer survey tissue array (5 of 5), including TNM, clinical stage and pathology grade, 208 cases/208 cores

124

BR20838

13

16

118

208

Breast

Multiple organs tumor tissue array, including pathology grade, TNM, clinical stage 118 cases/208 cores

125

BR2085c

13

16

188

208

Breast

Breast cancer with breast tissue array, including pathology grade, TNM and clinical stage, 188 cases/208 cores, replacing BR2085b

126

BR248a

4

6

24

24

Breast

Breast cancer tissue array with normal tissue, including pathology grade, TNM and clinical stage, 24 cases/24 cores, replacing BR248

127

BR251d

3

8

6

24

Breast

Breast cancer with matched breast tissue array, including pathology grade, TNM and clinical stage, 6 cases/24 cores, replacing BR251c

128

BR401

5

8

20

40

Breast

Breast mastitis tissue array, 20 cases/40 cores

129

BR402

5

8

20

40

Breast

Breast mastitis tissue array, 20 cases/40 cores

130

BR484b

6

8

48

48

Breast

Breast cancer tissue array, including pathology grade, TNM and clinical stage, 48 cases/48 cores, replacing BR484a

131

BR485

6

16

48

96

Breast

Breast cancer and normal tissue array, including pathology grade, TNM and clinical stage, 2 serial sections, 48 cases/96 cores

132

BR601a

6

10

30

60

Breast

Breast fibroadenoma tissue array, 30 cases/ 60 cores, replacing BR601

133

BR641

8

8

64

64

Breast

Breast cancer tissue array, including pathology grade, TNM and clinical stage, 64 cases/ 64 cores

134

BR727

8

9

64

64

Breast

Breast cancer tissue array, including pathology grade, TNM and clinical stage, 24 cases/72 cores

135

BR728

8

9

24

72

Breast

Breast cancer tissue array, including pathology grade, TNM and clinical stage, 24 cases/72 cores, replacing BC08015

136

BR8010

8

10

71

80

Breast

Breast fibroadenoma, breast tissue and breast cancer array, including pathology grade, TNM and clinical stage, 71 cases/80 cores

137

BR8017

8

10

80

80

Breast

Middle-advanced stage breast cancer tissue array, with metastasis tissue, including pathology grade, TNM and clinical stage, 80 cases/80 cores

138

BR8018

8

10

80

80

Breast

Breast invasive ductal carcinoma tissue array, including pathology grade, TNM and clinical stage, 80 cases/80 cores, replacing BR808, BC08014

139

BR802b

8

10

47

80

Breast

Breast invasive ductal carcinoma with matched or unmatched adjacent normal breast tissue array, including pathology grade, TNM and clinical stage, 47 cases/80 cores, replacing BR802

140

BR901

9

10

45

90

Breast

Breast cancer tissue array (pathology grade:1,2,3), including pathology grade, TNM and clinical stage, 45 cases/90 cores

141

BR965

8

12

48

96

Breast

Breast cancer tissue array, including pathology grade, TNM and clinical stage, 48 cases/96 cores, replacing BRC962

142

BRC051

1

5

5

5

Breast

Breast cancer tissue array with normal breast tissue, including pathology grade, TNM, clinical stage, 5 cases/5 cores

143

BRE1121

10

12

112

112

Breast

Triple negative breast cancer with normal tissue array, including pathology grade, TNM, clinical stage, 112 cases/112 cores

144

BRE1201

10

12

120

120

Breast

Breast cancer tissue array (most of triple negative), including pathology grade, TNM, clinical stage, 120 cases/120 cores

145

BRE501

6

9

50

50

Breast

Breast cancer with breast tissue array (2012 WHO classification), including pathology grade, TNM and clinical stage (AJCC 7th edition), 50 cases/50 cores

146

BRE502

6

9

31

50

Breast

Breast cancer with breast tissue array, including pathology grade, TNM and clinical stage, 31 cases/50 cores

147

BRN04

1

4

4

4

Breast

Breast tissue array, 4 cases/4 cores

148

FBR087d

3

8

6

24

Breast

Breast cancer with breast tissue array, including pathology grade, TNM and clinical stage, 6 cases/24 cores, replacing T087c

149

FBR-245b

4

6

12

24

Breast

Breast cancer with adjacent normal tissue array (2012 WHO classification), including pathology grade, TNM and clinical stage (AJCC 7th edition), 12 cases/24 cores, replacing BR245a

150

FMG010

3

4

10

10

Breast

Breast invasive carcinoma of no special type tissue array, including pathology grade, TNM, clinical stage, 10 cases/10 cores

151

FMG08013e

8

9

72

72

Breast

Breast cancer with adjacent normal breast tissue array, including pathology grade, TNM and clinical stage, 72 cases/72 cores, replacing BC08013d

152

FMG08013f

8

9

72

72

Breast

Breast cancer with adjacent normal breast tissue array, including pathology grade, TNM and clinical stage, 72 cases/72 cores, replacing FMG08013e

153

FMG082a

2

4

4

8

Breast

Breast cancer tissue array, including pathology grade, TNM and clinical stage, 4 cases/8 cores, replacing BR082

154

FMG1001

10

10

96

100

Breast

Breast cancer and breast tissue array, with metastatic carcinoma, including pathology grade, TNM and clinical stage, 96 cases/100 cores

155

FMG1003b

10

11

47

101

Breast

Multiple types breast cancer tissue array, including pathology grade, TNM and clinical stage, 47 cases/101 cores, replacing BR1003a

156

FMG1009

10

10

50

100

Breast

Breast cancer tissue array with normal tissue, including pathology grade, TNM and clinical stage, 50 cases/100 cores

157

FMG1021

8

13

102

102

Breast

Multiple types breast cancer tissue array with adjacent normal tissue, including pathology grade, TNM and clinical stage, 102 cases/102 cores

158

FMG1141

11

11

114

114

Breast

Breast cancer tissue array, including pathology grade, TNM and clinical stage, 114 cases/114 cores

159

FMG1503

10

15

75

150

Breast

Breast cancer tissue array, including pathology grade, TNM and clinical stage, 75 cases/150 cores

160

FMG1504

10

15

75

150

Breast

Breast cancer tissue array with adjacent normal breast tissue, including pathology grade, TNM and clinical stage, 75 cases/150 cores

161

FMG1505c

10

15

75

150

Breast

Breast cancer tissue array, including pathology grade, TNM and clinical stage, 75 cases/150 cores, replacing BR1505b

162

FMG2088

13

16

104

208

Breast

Breast cancer tissue array, including pathology grade, TNM and clinical stage, 104 cases/208 cores

163

FMG2089

13

16

104

208

Breast

Breast cancer tissue array, including pathology grade, TNM, clinical stage, 104 cases/208 cores

164

FMG246

4

6

12

24

Breast

Breast carcinoma tissue array, including pathology grade, TNM and clinical stage, 12 cases/24 cores, replacing BR245

165

FMG247

3

8

6

24

Breast

Breast cancer tissue array with adjacent normal tissue, including pathology grade, TNM and clinical stage, 6 cases/24 cores

166

FMG251a

3

8

6

24

Breast

Breast cancer tissue array with matched adjacent normal breast tissue, including pathology grade, TNM and clinical stage, 6 cases/24 cores, replacing BR251

167

FMG251c

3

8

6

24

Breast

Breast cancer with matched breast tissue array, including pathology grade, TNM and clinical stage, 6 cases/24 cores, replacing BR251b

168

FMG252

4

6

12

24

Breast

Breast cancer with matched breast tissue array, including pathology grade, TNM and clinical stage, 12 cases/24 cores

169

FMG351

5

7

35

35

Breast

Low differentiated breast cancer tissue array, including pathology grade, TNM and clinical stage, 35 cases/35 cores

170

FMG483b

6

8

48

48

Breast

Breast cancer tissue array with normal tissue, including pathology grade, TNM and clinical stage, 48 cases/48 cores, replacing BR483

171

FMG483c

6

8

48

48

Breast

Breast cancer tissue array with normal tissue, including pathology grade, TNM and clinical stage, 48 cases/48 cores, replacing BR483b

172

FMG484

6

8

48

48

Breast

Breast cancer tissue array, including TNM, clinical stage and pathology grade, 48 cases/48 cores

173

FMG501

5

10

50

50

Breast

Breast cancer tissue array, including pathology grade, TNM and clinical stage, 50 cases/ 50 cores

174

FMG631

7

9

45

63

Breast

Breast cancer tissue array, with adjacent normal tissue and cancer adjacent breast tissue, including pathology grade, TNM and clinical stage, 45 cases/63 cores

175

FMG721

8

9

72

72

Breast

Breast cancer tissue array, including pathology grade, TNM and clinical stage, 72 cases/72 cores

176

FMG802c

8

10

54

80

Breast

Breast cancer with matched or unmatched breast tissue array, including pathology grade, TNM and clinical stage, 54 cases/80 cores, replacing BR802b

177

FMG803b

8

10

80

80

Breast

Breast cancer tissue array, including pathology grade, TNM and clinical stage, 80 cases/80 cores, replacing BR803a

178

FMG805

8

10

80

80

Breast

Breast cancer tissue array, including TNM and clinical stage, 80 cases/80 cores

179

FMG807

8

10

80

80

Breast

Breast cancer tissue array, including TNM and clinical stage, 80 cases/80 cores

180

FMG809

8

10

80

80

Breast

Breast cancer tissue array with normal tissue, including pathology grade, TNM and clinical stage, 80 cases/80 cores

181

HER2c

3

4

10

10

Breast

Her-2 IHC Bio-marker control TMA, with breast invasive carcinoma of no special type, including pathology grade, TNM, clinical stage and, 10 cases/10 cores, replacing Her2b

182

PM2b-ER

3

4

10

10

Breast

Breast invasive carcinoma tissue array, including pathology grade, TNM and clinical stage, 10 cases/ 10 cores

183

S-FMG133M

10

14

62

133

Breast

Triple negative breast tissue array with survival data, including prognosis, pathology grade, TNM and clinical stage , 62 cases/133 cores

184

S-FMG140M

12

12

70

140

Breast

Breast carcinoma (Her2 3+) tissue array with survival data, including prognosis, pathology grade, TNM and clinical stage, 70 cases/140 cores.

185

S-FMG142M

11

14

71

142

Breast

Breast carcinoma (HR) tissue array with survival data, including prognosis, pathology grade, TNM and clinical stage, 71 cases/142 cores.

186

T088e

3

8

6

24

Breast

Breast cancer with breast tissue array, including pathology grade, TNM and clinical stage, 6 cases/24 cores, replacing T088d

187

T089b

4

6

6

24

Breast

Breast cancer tissue array, including pathology grade, TNM and clinical stage, 6 cases/24 cores, replacing T089a

188

FDU631

7

9

63

63

Cervix

Cervix cancer tissue array with adjacent normal and cancer adjacent tissue, including pathology grade, TNM and clinical stage, 63 cases/63 cores

189

BIC05011

6

8

24

48

Colon

Colon intraepithelial neoplasia tissue array, 24 cases/48 cores

190

CO1006

10

10

50

100

Colon

Colon carcinoma tissue array, including pathology grade, TNM and clinical stage, 50cases/100 cores

191

CO1021b

8

13

102

102

Colon

Colon cancer with colon tissue array, including pathology grade, TNM and clinical stage, 102 cases/102 cores replacing CO1021a

192

CO1801b

10

18

90

180

Colon

Colon cancer with matched colon tissue array(2010 WHO classification), including pathology grade, TNM and clinical stage (AJCC 7th edition), 90 cases/180 cores, replacing CO1801a

193

CO2001b

13

16

200

200

Colon

Colon cancer with adjacent normal colon tissue array, including pathology grade, TNM and clinical stage, 200 cases/ 200 cores, replacing CO2001a

194

CO20811

13

16

208

208

Colon

Colon tumor survey tissue array (1 of 4), including pathology grade, TNM and clinical stage, 208 cases/208 cores

195

CO20813

13

16

208

208

Colon

Colon tumor survey tissue array (3 of 4), including pathology grade, TNM and clinical stage, 208 cases/208 cores

196

CO20814

13

16

208

208

Colon

Colon tumor survey tissue array (4 of 4), including pathology grade, TNM and clinical stage, 208 cases/208 cores

197

CO2081a

13

16

104

208

Colon

Colon disease spectrum tissue array with normal tissue, including pathology grade, TNM and clinical stage, 104 cases/208 cores, replacing CO2081

198

CO2085b

13

16

208

208

Colon

High-density (208 cores), multiple types colon cancer tissue array with normal colon tissue (from autopsy and adjacent normal tissue), including pathology grade, TNM and clinical stage, 208 cases/208 cores, replacing CO2085a

199

CO2161a

12

18

216

216

Colon

Colon cancer and colon tissue array, including pathology grade, TNM and clinical stage, 216 cases/216 cores, replacing CO2161

200

CO483a

6

8

48

48

Colon

Colon cancer tissue array with normal tissue, including pathology grade, TNM and clinical stage, 48 cases/48 cores, replacing CO483

201

CO486b

6

16

48

96

Colon

Colon cancer tissue array, including pathology grade, TNM and clinical stage, 2 serial sections, 48 cases/96 cores, replacing CO486a

202

CO489d

6

8

24

48

Colon

Colon adenocarcinoma stage III tissue array, including pathology grade, ,TNM and clinical stage, non-overlapping with other CO489, 24 cases/48 cores

203

CO489e

6

8

24

48

Colon

Colon adenocarcinoma stage III tissue array, including pathology grade, TNM and clinical stage, non-overlapping with other CO489, 24 cases/ 48 cores

204

CO489f

6

8

24

48

Colon

Colon adenocarcinoma stage III tissue array, including pathology grade, TNM and clinical stage, non-overlapping with other CO489, 24 cases/ 48 cores

205

CO489i

6

8

24

48

Colon

Colon adenocarcinoma stage III tissue array, including pathology grade, TNM and clinical stage, non-overlapping with other CO489, 24 cases/48 cores

206

CO489j

6

8

24

48

Colon

Colon adenocarcinoma stage III tissue array, including pathology grade, TNM and clinical stage, non-overlapping with other CO489, 24 cases/ 48 cores

207

CO489k

6

8

24

48

Colon

Colon adenocarcinoma stage III tissue array, including pathology grade, TNM and clinical stage, non-overlapping with other CO489, 24 cases/ 48 cores

208

CO489n

6

8

24

48

Colon

Colon adenocarcinoma stage II tissue array, including pathology grade, TNM and clinical stage, non-overlapping with other CO489, 24 cases/48 cores

209

CO489p

6

8

24

48

Colon

Colon adenocarcinoma stage II tissue array, including pathology grade, TNM and clinical stage, non-overlapping with other CO489, 24 cases/48 cores

210

CO489q

6

8

24

48

Colon

Colon adenocarcinoma stage II tissue array, including pathology grade, TNM and clinical stage, non-overlapping with other CO489, 24 cases/48 cores

211

CO489t

6

8

24

48

Colon

Colon adenocarcinoma stage II tissue array, including pathology grade, TNM and clinical stage, non-overlapping with other CO489, 24 cases/48 cores

212

CO489u

6

8

24

48

Colon

Colon adenocarcinoma stage II tissue array, including pathology grade, TNM and clinical stage, non-overlapping with other CO489, 24 cases/ 48 cores

213

CO602

6

10

30

60

Colon

Colon cancer with matched cancer adjacent colon tissue, including pathology grade, TNM and clinical stage, 30 cases/60 cores

214

CO702c

7

10

69

69

Colon

Colon cancer and colon tissue array, with metastasis carcinoma, including pathology grade, TNM and clinical stage, 69 cases/69 cores, replacing CO702b

215

CO726

8

9

24

72

Colon

Metastatic carcinoma from colon tissue array, including pathology grade, 24 cases/72 cores, replacing BC050112

216

CO802e

8

10

80

80

Colon

Colon cancer with adjacent normal colon tissue array, including pathology grade, TNM and clinical stage, 80 cases/80 cores, replacing CO802d

217

CO803a

8

10

40

80

Colon

Colon cancer tissue array with matched cancer adjacent colon tissue, including pathology grade, TNM and clinical stage, 40 cases/80 cores, replacing CO803

218

CO804a

8

10

80

80

Colon

Colon cancer tissue array, including pathology grade, TNM and clinical stage, 80 cases/80 cores, replacing CO804

219

CO809a

8

10

77

80

Colon

Colon disease tissue array , including pathology grade, TNM and clinical stage, 80 cases/80 cores, replacing CO809

220

CO953

8

12

39

95

Colon

Colon cancer tissue array with matched normal adjacent and matched or unmatched metastatic carcinoma tissue, including pathology grade, TNM, clinical stage and survival data, 39 cases/95 cores, replacing CO952a

221

COL501

6

9

50

50

Colon

Colon adenocarcinoma with colon tissue array (2010 WHO classification), including pathology grade, TNM and clinical stage (AJCC 7th edition), 50 cases/50 cores

222

COL502

6

9

25

50

Colon

Colon adenocarcinoma with matched colon tissue array (2010 WHO classification), including pathology grade, TNM and clinical stage (AJCC 7th edition), 25 cases/50 cores

223

DCO053d

3

8

6

24

Colon

Colon cancer tissue array with normal tissue, including pathology grade, TNM and clinical stage, 6 cases/24 cores, replacing T053c

224

DCO054d

3

8

12

24

Colon

Colon cancer tissue array with normal colon tissue, including pathology grade, TNM and clinical stage, 12 cases/24 cores, replacing T054c

225

DCO054e

3

8

13

24

Colon

Colon cancer tissue array with normal colon tissue, including pathology grade, TNM and clinical stage, 12 cases/ 24 cores, replacing T054d

226

DCO-055b

4

6

6

24

Colon

Colon cancer tissue array (4x(2x3) array), including pathology grade, TNM and clinical stage, 6 cases/24 cores, replacing T055a

227

DCO1002c

10

10

64

100

Colon

Colorectal carcinoma and matched colon tissue array (2010 WHO classification), with lymph node metastasis carcinoma, including pathology grade, TNM and clinical stage (AJCC 7th edition), 64 cases/100 cores, replacing CO1002b

228

DCO1003

10

10

100

100

Colon

Colon cancer with metastatic carcinoma tissue array, including pathology grade, 100 cases/100 cores

229

DCO1005

10

10

100

100

Colon

Colon cancer and adenoma tissue array with normal tissue, including pathology grade, TNM and clinical stage, 100 cases/100 cores

230

DCO-1021b

8

13

102

102

Colon

Colon cancer with colon tissue array, including pathology grade, TNM and clinical stage, 102 cases/102 cores, replacing CO1021a

231

DCO1301

10

13

100

130

Colon

Colon adenocarcinoma tissue array with colon inflammation and colon tissue, including pathology grade, TNM and clinical stage, 100 cases/130 cores

232

DCO1501a

10

15

75

150

Colon

Colon adenocarcinoma tissue array, including pathology grade, TNM and clinical stage, 75 cases/150 cores

233

DCO1601

10

16

80

160

Colon

Colon cancer tissue array with matched adjacent normal or cancer adjacent tissue, including pathology grade, TNM and clinical stage, 80 cases/160 cores

234

DCO-1801b

10

18

90

180

Colon

Colon cancer with matched colon tissue array (2010 WHO classification), including pathology grade, TNM and clinical stage (AJCC 7th edition), 90 cases/180 cores, replacing CO1801a

235

DCO20810

13

16

104

208

Colon

Colon tumor survey tissue array (5 of 5), including pathology grade, TNM and clinical stage, 104 cases/208 cores

236

DCO20812

13

16

104

208

Colon

Colon cancer survey tissue array (2 of 4), including pathology grade, TNM and clinical stage, 208 cases/208 cores, replacing CO20812

237

DCO2087

13

16

104

208

Colon

Colon tumor survey tissue array (2 of 5), including pathology grade, TNM and clinical stage, 104 cases/208 cores

238

DCO241

4

6

6

24

Colon

Colon tissue and polyp tissue array, 6 cases/24 cores

239

DCO241b

3

8

6

24

Colon

Colon cancer tissue array with adjacent normal colon tissue, including pathology grade, TNM and clinical stage, 6 cases/24 cores, replacing CO241a

240

DCO243

4

6

9

24

Colon

Colon cancer tissue array with matched adjacent normal tissue, including pathology grade, TNM and clinical stage, 9 cases/24 cores

241

DCO2601

13

20

65

260

Colon

Colon cancer tissue array with matched cancer adjacent colon tissue, including pathology grade, TNM, clinical stage, 65 cases/260 cores

242

DCO321

4

8

16

32

Colon

Colon cancer (grade II) with matched adjacent normal colon tissue, including pathology grade, TNM and clinical stage, 16 cases/32 cores

243

DCO351

5

7

35

35

Colon

Colon adenocarcinoma (grade I) tissue array, including pathology grade, TNM and clinical stage, 35 cases/35 cores

244

DCO352

5

7

35

35

Colon

Colon adenocarcinoma tissue array, including pathology grade, TNM and clinical stage, 35 cases/35 cores

245

DCO353

5

7

35

35

Colon

Colon adenocarcinoma (grade III) tissue array, including pathology grade, TNM and clinical stage, 35 cases/35 cores, replacing CO353

246

DCO482a

6

8

24

48

Colon

Colon cancer with normal tissue array, including pathology grade, TNM and clinical stage, 24 cases/48 cores

247

DCO484a

6

8

48

48

Colon

Colon cancer tissue array with adjacent normal tissues, including pathology grade, TNM and clinical stage, 48 cases/48 cores, replacing CO484

248

DCO488

6

8

16

48

Colon

Colon adenocarcinoma array with matched cancer adjacent colon tissue, including pathology grade, TNM and clinical stage, 16 cases/48 cores

249

DCO489b

6

8

24

48

Colon

Colon adenocarcinoma stage III and stage IV tissue array, including pathology grade, TNM and clinical stage, non-overlapping with other CO489, 24 cases/48 cores

250

DCO489c

6

8

24

48

Colon

Colon adenocarcinoma stage III tissue array, including pathology grade, TNM and clinical stage, non-overlapping with other CO489, 24 cases/48 cores

251

DCO489g

6

8

24

48

Colon

Colon adenocarcinoma stage III tissue array, including pathology grade, TNM and clinical stage, non-overlapping with other CO489, 24 cases/48 cores

252

DCO489h

6

8

24

48

Colon

Colon adenocarcinoma stage III tissue array, including pathology grade, TNM and clinical stage, non-overlapping with other CO489, 24 cases/48 cores

253

DCO489l

6

8

24

48

Colon

Colon adenocarcinoma stage III tissue array, including pathology grade, TNM and clinical stage, non-overlapping with other CO489, 24 cases/48 cores

254

DCO489m

6

8

24

48

Colon

Colon adenocarcinoma stage II tissue array, including pathology grade, TNM and clinical stage, non-overlapping with other CO489, 24 cases/48 cores

255

DCO489r

6

8

24

48

Colon

Colon adenocarcinoma stage II tissue array, including pathology grade, TNM and clinical stage, non-overlapping with other CO489, 24 cases/48 cores

256

DCO489s

6

8

24

48

Colon

Colon adenocarcinoma stage II tissue array, including pathology grade, TNM and clinical stage, non-overlapping with other CO489, 24 cases/48 cores

257

DCO601

6

10

30

60

Colon

Colon cancer (stage I) with matched cancer adjacent colon tissue, including pathology grade, TNM and clinical stage, 30 cases/60 cores

258

DCO-701a

7

10

70

70

Colon

Colon cancer with colon tissue array (2010 WHO classification), including pathology grade, TNM and clinical stage (AJCC 7th edition), 70 cases/70 cores, replacing CO701

259

DCO-702c

7

10

69

69

Colon

Colon cancer tissue array with metastatic cancer and normal tissue (2010 WHO classification), including pathology grade, TNM and clinical stage (AJCC 7th edition), 69 cases/69 cores, replacing CO702b

260

DCO703

7

10

35

70

Colon

Colon cancer tissue array with matched adjacent normal colon tissue, including pathology grade, TNM and clinical stage, 35 cases/70 cores

261

DCO721

8

9

24

72

Colon

Colon normal tissue array, including pathology grade, TNM and clinical stage, 24 cases/72 cores, replacing BN05011

262

DCO722a

8

9

24

72

Colon

Colon carcinoma, cancer adjacent and adjacent normal tissue array, including pathology grade, TNM and clinical stage, 24 cases/72 cores

263

DCO723

8

9

24

72

Colon

Colon well-differentiated adenocarcinoma tissue array with adjacent normal tissue, including pathology grade, TNM and clinical stage, 24 cases/72 cores, replacing BS05021

264

DCO724

8

9

24

72

Colon

Colon moderately differentiated adenocarcinoma tissue array with adjacent normal tissue, including pathology grade, TNM and clinical stage, 24 cases/72 cores, replacing BS05031

265

DCO8010

8

10

80

80

Colon

Mid-advanced stage colon cancer tissue array, including pathology grade, TNM and clinical stage, 80 cases/80 cores

266

DCO802c

8

10

80

80

Colon

Colon cancer tissue array with adjacent normal colon tissue, including pathology grade, TNM and clinical stage, 80 cases/80 cores, replacing CO802b

267

DCO803b

8

10

40

80

Colon

Colon cancer tissue array with matched cancer adjacent colon tissue, including pathology grade, TNM and clinical stage, 40 cases/80 cores

268

DCO901

9

10

50

90

Colon

Colon cancer tissue array with adjacent normal colon tissue, including pathology grade, TNM and clinical stage, 50 cases/90 cores

269

DCO963

8

12

48

96

Colon

Colon adenocarcinoma (grade II) tissue array, including pathology grade, TNM and clinical stage, 48 cases/96 cores

270

DCOL721

8

9

72

72

Colon

Colon cancer tissue array, including pathology grade, TNM and clinical stage, 72 cases/72 cores

271

DCR1201

10

12

60

120

Colon

Colorectal cancer tissue array with matched adjacent normal or cancer adjacent tissue, including pathology grade, TNM and clinical stage, 60 cases/120 cores

272

S-CRAC1601C

8

10

80

80

Colon

Colon cancer tissue microarray chip with survival data, 80 cases/80 cores.

273

S-CRAC3204M

10

16

80

160

Colon

Colon cancer tissue/matched normal tissue array with survival data, including survival status, pathology grade, TNM and clinical stage, 80 cases/160 cores

274

T056a

4

6

12

24

Colon

Colon cancer with colon tissue array, including pathology grade, TNM and clinical stage, 6 cases/24 cores, replacing T056

275

EMT241

3

8

6

24

Embryonic Tumors

Embryonal tumor test tissue array, with normal tissue, including pathology grade, TNM and clinical stage, 6 cases/24 cores, replacing T001

276

FUR1001

10

10

25

100

Endometrium

Endometrial cancer tissue array for antibody screening, including pathology grade, TNM and clinical stage, 25 cases/100 cores

277

FUR1021

8

13

102

102

Endometrium

Endometrial cancer tissue array, including pathology grade, TNM and clinical stage, 102 cases/102 cores

278

FUR1021b

8

13

102

102

Endometrium

Endometrium cancer with endometrium tissue array, including pathology grade, TNM and clinical stage, 102 cases/102 cores, replacing EM1021a

279

FUR1501

10

15

75

150

Endometrium

Uterus cancer tissue array, including pathology grade, TNM and clinical stage, 75 cases/150 cores

280

FUR1502

10

15

75

150

Endometrium

Endometrium cancer tissue array, including pathology grade, TNM and clinical stage, 75 cases/150 cores

281

FUR240

4

6

24

24

Endometrium

Endometrium cancer, endometrium hyperplasia tissue array with adjacent tissue as control, including pathology grade, TNM and clinical stage, 24 cases/24 cores

282

FUR241

3

8

12

24

Endometrium

Endometrium cancer test tissue array with normal tissue, including pathology grade, TNM and clinical stage, 12cases/24cores, replacing T092

283

FUR242

4

6

6

24

Endometrium

Endometrium cancer test tissue array (4x (2x3)array), including pathology grade, TNM and clinical stage, 6 cases/24 cores

284

FUR243b

4

6

12

24

Endometrium

Endometrium cancer tissue array with matched cancer adjacent endometrium tissue, including pathology grade, TNM and clinical stage, 12 cases/24 cores, replacing UT243a

285

FUR244

4

6

12

24

Endometrium

Chorionic carcinoma with endometrium tissue array, including TNM and clinical stage, 12 cases/24 cores

286

FUR244a

4

6

12

24

Endometrium

Chorionic carcinoma with endometrium tissue array, including TNM and clinical stage, 12 cases/24 cores

287

FUR481

6

8

48

48

Endometrium

Endometrium cancer tissue array, including pathology grade, TNM and clinical stage, 48 cases/48 cores

288

FUR501b

5

10

50

50

Endometrium

Endometrioid carcinoma tissue array with normal tissue, including pathology grade, TNM and clinical stage, 50 cases/50 cores, replacing UT501a

289

FUR631

7

9

63

63

Endometrium

Endometrioid cancer tissue array, including pathology grade, TNM and clinical stage, 63 cases/63 cores

290

FUR721

8

9

24

72

Endometrium

Uterus cancer with normal tissue array, including pathology grade, TNM and clinical stage, 24 cases/72 cores

291

FUR801b

8

10

80

80

Endometrium

Endometrial disease spectrum (endometrial cancer progression) tissue array, including pathology grade, TNM and clinical stage, 80 cases/80 cores, replacing UT801a

292

FUR803

8

10

40

80

Endometrium

Uterus cancer with endometrium tissue array, including pathology grade, TNM and clinical stage, 40 cases/80 cores

293

UT243

4

6

12

24

Endometrium

Endometrium cancer tissue array with matched adjacent endometrium tissue, including TNM, clinical stage and pathology grade, 12 cases/24 cores

294

UTN801a

8

10

79

80

Endometrium

Endometrium tissue and endometrium cancer tissue array, including pathology grade, TNM and clinical stage, 79 cases/80 cores, replacing UTN801

295

KIN601

6

10

60

60

Epiploon

Metastatic carcinoma of epiploon

296

BC001113a

7

8

50

50

Esophagus

Esophagus, cardia cancer tissue array with normal tissue, including pathology grade, TNM and clinical stage, 50 cases/50 cores, replacing BC001113

297

BC001113b

7

8

50

50

Esophagus

Esophagus, cardia cancer tissue array with cancer adjacent tissue, including pathology grade, TNM and clinical stage, 50 cases/50 cores, replacing BC001113a

298

BN02014

8

10

80

80

Esophagus

Esophagus tissue with esophagus cancer tissue array, including pathology grade, TNM and clinical stage, 80 cases/80 cores

299

DES02012

8

9

72

72

Esophagus

Esophagus cancer with adjacent normal esophagus tissue array, including pathology grade, TNM and clinical stage, 72 cases/72 cores

300

DES02012b

8

9

72

72

Esophagus

Esophagus cancer with adjacent normal esophagus tissue array, including pathology grade, TNM and clinical stage, 72 cases/72 cores, replacing BC02012a

301

DES1002

10

10

50

100

Esophagus

Esophagus cancer tissue array, including pathology grade, TNM and clinical stage, 50 cases/100 cores

302

DES1021

8

13

102

102

Esophagus

Esophagus cancer tissue array, including pathology grade, TNM and clinical stage, 102 cases/102 cores

303

DES1022

8

13

102

102

Esophagus

Different stages of esophagus cancer and esophagus tissue array, including pathology grade, TNM and clinical stage, 102 cases/102 cores

304

DES1202

10

12

60

120

Esophagus

Esophagus squamous cell carcinoma tissue array with matched adjacent normal or cancer adjacent esophagus tissue, including pathology grade, TNM and clinical stage, 60 cases/120 cores

305

DES1501

10

15

75

150

Esophagus

Esophagus squamous cell carcinoma with esophagus tissue array, including pathology grade, TNM and clinical stage, 75 cases/150 cores

306

DES1502

10

15

75

150

Esophagus

Esophagus cancer tissue array, including pathology grade, TNM and clinical stage, 75 cases/150 cores

307

DES1503

10

15

50

150

Esophagus

Esophagus cancer tissue array with matched cancer adjacent tissue, including pathology grade, TNM and clinical stage, 50 cases/150 cores

308

DES1504

10

15

50

150

Esophagus

Esophagus cancer tissue array with matched cancer adjacent tissue, including pathology grade, TNM and clinical stage, 50 cases/150 cores

309

DES1505

10

15

50

150

Esophagus

Esophagus squamous cell carcinoma with matched cancer adjacent tissue and esophagus lymph node tissue array, including pathology grade, TNM and clinical stage, 50 cases/150 cores

310

DES1921

12

16

96

192

Esophagus

Middle-advanced stage esophagus cancer tissue array, including pathology grade, TNM and clinical stage, 96 cases/192 cores

311

DES1922

12

16

96

192

Esophagus

Esophagus squamous cell carcinoma with matched adjacent normal esophagus tissue array, including pathology grade, TNM and clinical stage, 96 cases/192 cores

312

DES208

13

16

64

192

Esophagus

Esophagus cancer with esophagus tissue array, with metastatic carcinoma, including pathology grade, TNM and clinical stage, 69 cases/208 cores

313

DES241

3

8

12

24

Esophagus

Esophagus cancer test tissue array with normal tissue, including pathology grade, TNM and clinical stage, 12 cases/24 cores, replacing T022

314

DES242

3

8

12

24

Esophagus

Esophagus cancer array with normal tissue, including pathology grade, TNM and clinical stage, 12 cases/ 24 cores, replacing T022a

315

DES243

3

8

12

24

Esophagus

Esophagus cancer array with normal tissue, including pathology grade, TNM and clinical stage, 12 cases/24 cores, replacing T022b

316

DES244

4

6

12

24

Esophagus

Esophagus squamous cell carcinoma tissue array with matched cancer adjacent tissue, including pathology grade, TNM and clinical stage, 12 cases/24 cores, replacing ESC241

317

DES245

4

6

6

24

Esophagus

Esophagus cancer test tissue array (4x (2x3)array), including pathology grade, TNM and clinical stage, 6 cases/24 cores

318

DES352

5

7

35

35

Esophagus

Esophagus squamous cell carcinoma (grade II) tissue array, including pathology grade, TNM and clinical stage, 35 cases/35 cores

319

DES353

5

7

35

35

Esophagus

Esophagus squamous cell carcinoma (grade III) tissue array, including pathology grade, TNM and clinical stage, 35 cases/35 cores

320

DES483

6

8

16

48

Esophagus

Esophagus cancer with matched cancer adjacent tissue array, including pathology grade, TNM and clinical stage, 16 cases/48 cores

321

DES484

6

8

24

48

Esophagus

Esophagus cancer tissue array, including pathology grade, TNM and clinical stage, 24 cases/ 48 cores

322

DES502

5

10

50

50

Esophagus

Esophagus squamous cell carcinoma tissue array, including pathology grade, TNM and clinical stage, 50 cases/50 cores

323

DES601

6

10

30

60

Esophagus

Esophagus squamous cell carcinoma tissue array with matched cancer adjacent esophagus tissue, including pathology grade, TNM and clinical stage, 30 cases/60 cores

324

DES701

7

10

35

70

Esophagus

Esophagus cancer tissue array with matched adjacent normal esophagus tissue, including pathology grade, TNM and clinical stage, 35 cases/70 cores

325

DES702

7

10

35

70

Esophagus

Multiple esophagus cancer tissue array with matched cancer adjacent normal tissue, including pathology grade, TNM and clinical stage, 35 cases/70 cores

326

DES721

8

9

72

72

Esophagus

Esophagus disease spectrum (esophageal cancer progression) tissue array, including pathology grade, TNM and clinical stage, 72 cases/72 cores

327

DES722

8

9

24

72

Esophagus

Esophagus cancer with esophagus tissue array, including pathology grade, TNM and clinical stage, 24 cases/72 cores

328

DES723

8

9

23

72

Esophagus

Esophagus cancer tissue array with adjacent normal tissue, including pathology grade, TNM and clinical stage, 23 cases/ 72 cores

329

DES8011a

8

10

40

80

Esophagus

Esophagus cancer and normal tissue array, including pathology grade, TNM and clinical stage, 40 cases/80 cores, replacing ES8011

330

DES8012

8

10

80

80

Esophagus

Middle-advanced stage esophagus cancer tissue array with metastasis tissue, including pathology grade, TNM and clinical stage, 80 cases/80 cores

331

DES901

10

9

30

90

Esophagus

Esophagus cancer and esophagus tissue array, including pathology grade, TNM and clinical stage, 30 cases/90 cores

332

DES902

10

9

45

90

Esophagus

Esophagus cancer with adjacent normal esophagus tissue array, including pathology grade, TNM and clinical stage, 45 cases/90 cores

333

DES961

8

12

48

96

Esophagus

Esophagus squamous cell carcinoma tissue array with normal tissue, including pathology grade, TNM and clinical stage, 48 cases/96 cores

334

DES962

8

12

48

96

Esophagus

Esophagus cancer tissue array, including pathology grade, TNM and clinical stage, 48 cases/96 cores, replacing ESC962

335

DES966

12

8

48

96

Esophagus

Esophagus cancer tissue array, including pathology grade, TNM and clinical stage, 48 cases/96 cores

336

DLV244

4

6

8

24

Esophagus

Liver cancer tissue array, including pathology grade, TNM and clinical stage, 8 cases/24 cores

337

ES2001a

13

16

120

200

Esophagus

Esophagus squamous cell carcinoma with matched adjacent normal esophagus tissue and metastatic carcinoma tissue array, including pathology grade, TNM and clinical stage, 120 cases/200 cores, replacing ES2001

338

ES208b

12

16

64

192

Esophagus

Esophagus cancer and esophagus tissue array, with metastatic carcinoma, including pathology grade, TNM and clinical stage, 64 cases/192 cores, replacing ES208a

339

ES351

5

7

35

35

Esophagus

Esophagus squamous cell carcinoma tissue array, including pathology grade, TNM and clinical stage, 35 cases/35 cores

340

ES810a

8

10

40

80

Esophagus

Esophagus cancer with matched lymph node metastatic carcinoma tissue array, including pathology grade, TNM and clinical stage, 40 cases/80 cores, replacing ES810

341

ESO501

6

9

50

50

Esophagus

Esophagus squamous cell carcinoma with esophagus tissue array (2010 WHO classification), including pathology grade, TNM and clinical stage (AJCC 7th edition), 50 cases/50 cores

342

ESO502

6

9

25

50

Esophagus

Esophagus cancer with matched esophagus tissue array (2010 WHO classification), including pathology grade, TNM and clinical stage (small cell carcinoma reference AJCC 8th edition), 25 cases/50 cores

343

T021b

3

8

6

24

Esophagus

Esophagus cancer tissue array with normal tissue, including pathology grade, TNM and clinical stage, 6 cases/24 cores, replacing T021a

344

FUT241

3

8

6

24

Fallopian Tube

Uterine tube tumor with uterine tube tissue test array, including pathology grade, TNM and clinical stage, 6 cases/24 cores

345

FET541

6

9

14

54

Fetus

Fetal multiple organ normal tissue array, 14 cases/54 cores

346

FET781

9

9

4

78

Fetus

Fetal multiple organ normal tissue array, 4 cases/78 cores

347

FET782

6

12

10

72

Fetus

Different gestational age of fetal multiple organ normal tissue array, 10 cases/72 cores

348

PLA241

4

6

12

24

Fetus

Placenta tissue array, 12 cases/24 cores

349

HNN501

6

9

50

50

Head Neck

Head and neck squamous cell carcinoma and normal tissue array (2017 WHO classification), including pathology grade, TNM and clinical stage (AJCC 8th edition),50 cases/50 cores

350

HNN502

6

9

25

50

Head Neck

Head and neck tumor and matched normal tissue array (2017 WHO classification), including pathology grade, TNM and clinical stage (AJCC 8th edition), 25 cases/50 cores

351

XHN241

3

8

6

24

Head Neck

Head and neck cancer with matched adjacent normal tissue array, including pathology grade, TNM and clinical stage, 6 cases/24 cores

352

XHN-242c

4

6

12

24

Head Neck

Head and neck cancer with normal tissue array, including pathology grad, TNM and clinical stage, 12 cases/24 cores, replacing HN242b

353

XHN243

4

6

12

24

Head Neck

Head and neck cancer with normal tissue array, including pathology grade, TNM and clinical stage, 12 cases/24 cores

354

XHN483

6

8

48

48

Head Neck

Head and neck cancer with normal tissue array, including pathology grade, TNM and clinical stage, 48 cases/48 cores

355

XHN801

8

10

40

80

Head Neck

Head and neck squamous cell carcinoma tissue array, including pathology grade, TNM and clinical stage, 40 cases/80 cores

356

XHN-802c

8

10

80

80

Head Neck

Multiple head and neck tumor with normal tissue array (2005 WHO classification), including pathology grade, TNM and clinical stage (AJCC 8th edition), 80 cases/80 cores, replacing HN802b

357

XHN803

8

10

80

80

Head Neck

Head and neck cancer tissue array with normal tissue, including pathology grade, TNM and clinical stage, 80 cases/80 cores

358

XHN811

9

9

27

81

Head Neck

Head and neck tumor tissue array with normal tissue, including pathology grade, TNM and clinical stage, 27 cases/81 cores

359

MHN241

4

6

6

24

Head Neck

Head and neck cancer tissue array, including pathology grade, TNM and clinical stage, 6 cases/24 cores

360

BC30013a

6

6

18

36

Heart

Heart disease and heart tissue array, 18 cases/36 cores, replacing BC30013

361

CHT241

3

8

6

24

Heart

Heart tumor and cardiac muscle tissue test array, including TNM and pathology grade, 2 serial sections, 6 cases/24 cores

362

HEN241

4

6

24

24

Heart

Normal heart tissue array, 24 cases/24 cores

363

ISN241

4

6

24

24

Immune System

Normal immune system tissue array, 24 cases/ 24 cores

364

MC1081a

11

10

108

108

Immune System

Immune multiple organs tumor and normal tissue array, 108 cases/108 cores, replacing MC1081

365

DIN1021

9

12

34

102

Intestine

Small intestine carcinoma tissue array with matched small intestine tissue, including pathology grade, TNM and clinical stage, 34 cases/102 cores

366

DIN1401

10

14

70

140

Intestine

Small intestine carcinoma tissue array with small intestine tissue, including pathology grade, TNM and clinical stage, 70 cases/140 cores

367

DIN241

4

6

6

24

Intestine

Small intestine adenocarcinoma and adjacent normal tissue array, including pathology grade, 6 cases/24 cores

368

DIN242

4

6

12

24

Intestine

Small intestine adenocarcinoma with small intestine tissue array, including pathology grade, 12 cases/24 cores

369

DIN243

3

8

6

24

Intestine

Small intestine cancer with small intestine test array, including pathology grade, TNM and clinical stage, 6 cases/24 cores

370

DIN805

8

10

80

80

Intestine

Small intestine disease spectrum tissue array, including pathology grade, TNM and clinical stage, 80 cases/80 cores

371

DIN901

9

10

34

90

Intestine

Small intestine stromal tumor tissue array, 34 cases/90 cores

372

T421a

3

8

6

24

Intestine

Small intestine carcinoma test tissue array with normal small intestine tissue, including pathology grade, TNM and clinical stage, 6 cases/24 cores, replacing T421

373

KD20810

13

16

208

208

Kidney

Kidney cancer survey tissue array (1 of 3), with normal tissue, including pathology grade, TNM and clinical stage, 208 cases/208 cores

374

KD20811

13

16

208

208

Kidney

Kidney cancer survey tissue array (2 of 3), including pathology grade, TNM and clinical stage, 208 cases/208 cores

375

KD20812

13

16

208

208

Kidney

Kidney cancer survey tissue array(3 of 3), including pathology grade, TNM and clinical stage, 208 cases/208 cores

376

KD2082b

12

16

96

192

Kidney

Kidney cancer with kidney tissue array, including pathology grade, TNM and clinical stage, 96 cases/192 cores, replacing KD2082a

377

KD601

6

10

30

60

Kidney

Kidney clear cell cancer tissue array with matched cancer adjacent kidney tissue, including pathology grade, TNM and clinical stage, pathology grade I-III, 30 cases/60 cores

378

KD602

6

10

30

60

Kidney

Kidney cancer tissue array with matched kidney tissue, including ISUP grade, TNM, stage and survival data, 30 cases/60 cores

379

KD801b

8

10

40

80

Kidney

Kidney cancer with matched kidney tissue array, including pathology grade, TNM and clinical stage, 40 cases/80 cores, replacing KD801a

380

KD991a

11

9

33

99

Kidney

Kidney cancer, cancer adjacent and adjacent normal kidney tissue array, including pathology grade, TNM and clinical stage, 33 cases/99 cores, replacing KD991

381

KID501

6

9

50

50

Kidney

Kidney clear cell carcinoma with kidney tissue array (2016 WHO classification), including pathology grade, TNM and clinical stage (AJCC 7th edition), 50 cases/50 cores

382

KID502

6

9

25

50

Kidney

Multiple kidney cancer with matched kidney tissue array (2016 WHO classification), including pathology grade, TNM and clinical stage (AJCC 7th edition), 25 cases/50 cores

383

T071a

3

8

6

24

Kidney

Kidney cancer test tissue array with normal kidney tissues, including pathology grade, TNM and clinical stage, 6 cases/24 cores, replacing T071

384

UKD-461

6

8

23

46

Kidney

Multiple kidney cancer with matched kidney tissue array (2016 WHO classification), including pathology grade, TNM and clinical stage (AJCC 7th edition), 23 cases/46 cores

385

UKN1002

10

10

50

100

Kidney

Kidney cancer tissue array with adjacent normal tissue, including pathology grade, TNM and clinical stage, 50 cases/100 cores

386

UKN1501

10

15

75

150

Kidney

Kidney cancer tissue array, including pathology grade, TNM and clinical stage, 75 cases/150 cores

387

UKN1503

10

15

50

150

Kidney

Kidney cancer tissue array with matched kidney tissue, including pathology grade, TNM and clinical stage, 50 cases/150 cores

388

UKN1504

10

15

50

150

Kidney

Kidney cancer tissue array with matched cancer adjacent tissue, including pathology grade, TNM and clinical stage, 50 cases/150 cores

389

UKN1921

12

16

96

192

Kidney

Middle-advanced stage kidney cancer tissue array, including pathology grade, TNM and clinical stage, 96 cases/192 cores

390

UKN2086

13

16

104

208

Kidney

Kidney tumor survey tissue array (2 of 5), including pathology grade, TNM and clinical stage, 104 cases/208 cores

391

UKN2087

13

16

104

208

Kidney

Kidney cancer survey tissue array(3 of 5), including pathology grade, TNM and clinical stage, 104 cases/208 cores

392

UKN2088

13

16

104

208

Kidney

Kidney cancer survey tissue array (4 of 5), including pathology grade, TNM and clinical stage, 104 cases/208 cores

393

UKN241

3

8

12

24

Kidney

Kidney cancer test tissue array with normal tissue, including pathology grade, TNM and clinical stage, 12 cases/24 cores, replacing T072

394

UKN242

4

6

6

24

Kidney

Kidney cancer test tissue array (4x (2x3)array), including pathology grade, TNM and clinical stage, 6 cases/24 cores

395

UKN243

4

12

48

48

Kidney

Kidney cancer tissue array with normal tissue, including pathology grade, TNM and clinical stage, 24 cases/48 cores

396

UKN244

4

6

24

24

Kidney

Normal kidney and cancer adjacent tissue array, 24 cases/ 24 cores

397

UKN246

4

6

24

24

Kidney

Transitional cell carcinoma of renal pelvis tissue array, including pathology grade, TNM and clinical stage, 24 cases/24 cores

398

UKN247

4

6

12

24

Kidney

Kidney cancer tissue array with matched cancer adjacent tissue, including pathology grade, TNM and clinical stage, 12 cases/24 cores

399

UKN2601

13

20

65

260

Kidney

Kidney cancer tissue array with matched cancer adjacent kidney tissue, including pathology grade, TNM and clinical stage, 65 cases/260 cores

400

UKN2602

13

20

65

260

Kidney

Kidney cancer tissue array with matched cancer adjacent kidney tissue, including pathology grade, TNM and clinical stage, 65 cases/260 cores

401

UKN321

4

8

16

32

Kidney

Kidney cancer tissue array with matched adjacent normal tissue, including pathology grade, TNM and clinical stage, 16 cases/32 cores

402

UKN482

7

8

24

48

Kidney

Kidney cancer with normal tissue array, including pathology grade, TNM and clinical stage, 24 cases/ 48 cores

403

UKN483

6

8

48

48

Kidney

Kidney cancer tissue array with adjacent normal tissue, including pathology grade, TNM, clinical stage, 48 cases/48 cores

404

UKN484

6

8

48

48

Kidney

Kidney cancer tissue array, including pathology grade, TNM and clinical stage, 48 cases/48 cores

405

UKN485

6

8

48

48

Kidney

Kidney cancer tissue array with normal tissue, including pathology grade, TNM, clinical stage, 48 cases/48 cores

406

UKN487

6

8

24

48

Kidney

Pediatric nephroblastoma tissue array, 24 cases/48 cores

407

UKN601

6

10

30

60

Kidney

Kidney clear cell cancer tissue array with matched kidney tissue, including pathology grade, TNM, 30 cases/60 cores

408

UKN602

6

10

30

60

Kidney

Different stage of kidney cancer tissue array with cancer adjacent tissue, including pathology grade, TNM and clinical stage, 30 cases/60 cores

409

UKN641

8

8

64

64

Kidney

Kidney cancer tissue array, including pathology grade, TNM and clinical stage, 64 cases/ 64 cores

410

UKN701

7

10

35

70

Kidney

Kidney cancer (grade I) tissue array with matched adjacent normal kidney tissue, including pathology grade, TNM and clinical stage, 35 cases/70 cores

411

UKN702

7

10

35

70

Kidney

Kidney cancer tissue array with matched adjacent normal kidney tissue, including pathology grade, TNM and clinical stage, 35 cases/70 cores

412

UKN804

8

10

80

80

Kidney

Multiple pathological types of kidney carcinoma tissue array with kidney tissue, including pathology grade, TNM, clinical stage , 80 cases/80 cores

413

UKN811

8

10

40

80

Kidney

Kidney cancer and kidney tissue array, including pathology grade, TNM and clinical stage, 40 cases/80 cores

414

UKN901

9

10

40

90

Kidney

Kidney cancer tissue array with matched adjacent normal kidney tissue, including pathology grade, TNM and clinical stage, 40 cases/90 cores

415

UNK801

8

10

40

80

Kidney

Kidney cancer tissue array, matched tumor and adjacent normal tissue

416

LYA501a

6

9

50

50

Larynx

Larynx and pharynx squamous cell carcinoma and normal tissue array, including pathology grade, TNM and clinical stage, 50 cases/50 cores

417

BC03114 (LV804)

8

10

38

80

Liver

Liver cancer with liver tissue array, including pathology grade, TNM and clinical stage, 38 cases/80cores, replacing BS03011

418

DCH1001

10

10

50

100

Liver

Gallbladder cancer tissue array with adjacent normal tissue, including pathology grade, TNM and clinical stage, 50 cases/100 cores

419

DCH901

9

10

75

75

Liver

Gallbladder cancer with adjacent normal tissue array, including pathology grade, TNM and clinical stage, 45 cases/90 cores

420

DGA2081

13

16

104

208

Liver

Gallbladder disease spectrum (cholecystic cancer progression) tissue array, including pathology grade, TNM and clinical stage, 104 cases/208 cores

421

DGA461

6

8

20

46

Liver

Gallbladder cancer with matched cancer adjacent tissue array, including pathology grade, TNM and clinical stage, 20 cases/46 cores